PatientsVille.com Logo

PatientsVille

Levemir Side Effects

Common Levemir Side Effects

The most commonly reported Levemir side effects (click to view or check a box to report):

Blood Glucose Increased (1010)
Hypoglycaemia (176)
Injection Site Erythema (131)
Blood Glucose Decreased (125)
Blood Glucose Fluctuation (117)
Injection Site Pruritus (99)
Injection Site Pain (98)
Nausea (73)
Injection Site Haemorrhage (73)
Injection Site Mass (69)
Dizziness (63)
Injection Site Bruising (61)
Hyperglycaemia (60)
Injection Site Haematoma (58)
Diabetes Mellitus Inadequate Control (58)
Pruritus (56)
Injection Site Swelling (52)
Headache (48)
Rash (47)
Weight Increased (47)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Levemir Side Effects Reported to FDA

The following Levemir reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Levemir on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Abdominal Mass, Local Swelling, Thrombosis, Injection Site Bruising
on Mar 11, 2014 Female from US , 82 years of age, weighting 209.0 lb, was diagnosed with and was treated with Levemir Flexpen. Directly after, patient experienced the unwanted or unexpected Levemir side effects: abdominal mass, local swelling, thrombosis, injection site bruising. Levemir Flexpen dosage: 37 Units, Qd.
Associated medications used:
  • Novolog Flexpen (Sliding Scale Tid)
  • Atorvastatin (10 Mg, Qd)
Patient was hospitalized.

Respiratory Disorder Neonatal, Jaundice Neonatal, Foetal Exposure During Pregnancy, Exposure During Breast Feeding
Patient was taking Levemir Flexpen. Patient felt the following Levemir side effects: respiratory disorder neonatal, jaundice neonatal, foetal exposure during pregnancy, exposure during breast feeding on Mar 10, 2014 from TR Additional patient health information: Female , weighting 7.94 lb, was diagnosed with and. Levemir Flexpen dosage: 16 U, Qd. Patient was hospitalized.

Thrombosis, Weight Increased
Adverse event was reported on Mar 06, 2014 by a Female taking Levemir (Dosage: 8 Units) was diagnosed with and. Location: US , 81 years of age, weighting 184.0 lb, After Levemir was administered, patient encountered several Levemir side effects: thrombosis, weight increased.
Multiple concurrent drugs taken:
  • Xarelto (20mg Once Daily)
  • Metformin (2000 Mg, Qd)
  • Levothyroxine (137 Ug, Qd)
  • Glyburide (10 Mg, Qd)


Liver Disorder, Enterocolitis
on Mar 17, 2014 Female from JP , 69 years of age, weighting 99.21 lb, was diagnosed with and was treated with Levemir Chu. Directly after, patient experienced the unwanted or unexpected Levemir side effects: liver disorder, enterocolitis. Levemir Chu dosage: Unk. Patient was hospitalized.


Hypoglycaemic Unconsciousness
on Jan 09, 2014 Male from US , 71 years of age, weighting 164.9 lb, was diagnosed with and was treated with Levemir. Patient felt the following Levemir side effects: hypoglycaemic unconsciousness. Levemir dosage: 31 U, Qd In Am, Subcutaneous. Patient was hospitalized.

Blood Glucose Increased
Patient was taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. After Levemir was administered, patient encountered several Levemir side effects: blood glucose increased on Jan 09, 2014 from US Additional patient health information: Female , 90 years of age, weighting 119.9 lb, was diagnosed with and. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A. Patient was hospitalized.

Blood Glucose Decreased
Adverse event was reported on Jan 09, 2014 by a Female taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l (Dosage: 50, Subcutaneous) was diagnosed with and. Location: US , 69 years of age, Directly after, patient experienced the unwanted or unexpected Levemir side effects: blood glucose decreased.
Associated medications used:
  • Gabapentin (gabapentin)
  • Metformin (metformin)
Patient was hospitalized.

Hyperglycaemic Unconsciousness
on Jan 09, 2014 Female from US , 62 years of age, weighting 192.0 lb, was diagnosed with and was treated with Levemir. Patient felt the following Levemir side effects: hyperglycaemic unconsciousness. Levemir dosage: N/A.
Multiple prescriptions taken:
  • Humalog (insulin Lispro)
  • Amlodipine (amlodipine)
  • Lyrica (pregabalin)


Hypoglycaemic Unconsciousness
on Jan 09, 2014 Female from US , 78 years of age, weighting 190.0 lb, was diagnosed with and was treated with Levemir (insulin Detemir) Solution For Injection, .0024mol/l. After Levemir was administered, patient encountered several Levemir side effects: hypoglycaemic unconsciousness. Levemir (insulin Detemir) Solution For Injection, .0024mol/l dosage: 30 U, Qd, Subcutaneous?.
Multiple concurrent drugs taken:
  • Glyburide (glibenclamide)


Hypoglycaemic Unconsciousness, Shock Hypoglycaemic, Tinnitus, Hyperhidrosis, Urinary Incontinence, Blood Glucose Increased
Patient was taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. Directly after, patient experienced the unwanted or unexpected Levemir side effects: hypoglycaemic unconsciousness, shock hypoglycaemic, tinnitus, hyperhidrosis, urinary incontinence, blood glucose increased on Jan 09, 2014 from US Additional patient health information: Female , 77 years of age, was diagnosed with and. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A.
Associated medications used:
  • Glibenase (glipizide)


Blood Glucose Decreased
Adverse event was reported on Jan 09, 2014 by a Female taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l (Dosage: N/A) was diagnosed with and. Location: US , 56 years of age, Patient felt the following Levemir side effects: blood glucose decreased.

Accidental Overdose, Blood Glucose Abnormal
on Jan 09, 2014 Male from US , 65 years of age, was diagnosed with and was treated with Levemir (insulin Detemir) Solution For Injection, .0024mol/l. After Levemir was administered, patient encountered several Levemir side effects: accidental overdose, blood glucose abnormal. Levemir (insulin Detemir) Solution For Injection, .0024mol/l dosage: 1000 U, Single.
Multiple concurrent drugs taken:
  • Novolog (insulin Aspart)


Blood Glucose Abnormal
on Jan 09, 2014 Female from US , 49 years of age, was treated with Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. Directly after, patient experienced the unwanted or unexpected Levemir side effects: blood glucose abnormal. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A.

Blood Glucose Decreased
Patient was taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. Patient felt the following Levemir side effects: blood glucose decreased on Jan 09, 2014 from US Additional patient health information: Female , 66 years of age, was diagnosed with and. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A.

Anaphylactic Reaction
Adverse event was reported on Jan 09, 2014 by a Female taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l (Dosage: 40 U, Bid, Subcutaneous) was diagnosed with and. Location: US , 40 years of age, weighting 229.9 lb, After Levemir was administered, patient encountered several Levemir side effects: anaphylactic reaction.
Multiple concurrent drugs taken:
  • Lisinopril And Hydrochlorothiazide (hydrochlorothiazide, Lisinopril)
Patient was hospitalized.

Urticaria
on Jan 09, 2014 Female from US , 71 years of age, was diagnosed with and was treated with Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. Directly after, patient experienced the unwanted or unexpected Levemir side effects: urticaria. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A.

Blood Glucose Decreased
on Jan 09, 2014 Male from US , 47 years of age, weighting 250.0 lb, was diagnosed with and was treated with Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. Patient felt the following Levemir side effects: blood glucose decreased. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: 60 Units Every Night At Bedtime, Subcutaneous.
Multiple prescriptions taken:
  • Novolog Flexpen (insulin Aspart) Solution For Injection, 100u/ml (Sliding Scale, About 10 5 Units Three Times Daily, Subcutaneous)


Blood Glucose Decreased, Blood Glucose Fluctuation, Diabetes Mellitus Inadequate Control
Patient was taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. After Levemir was administered, patient encountered several Levemir side effects: blood glucose decreased, blood glucose fluctuation, diabetes mellitus inadequate control on Jan 09, 2014 from US Additional patient health information: Female , 62 years of age, weighting 130.1 lb, was diagnosed with and. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A.
Multiple concurrent drugs taken:
  • Novolog Flexpen (insulin Aspart) Solution For Injection, 100u/ml (Sliding Scale, Subcutaneous)
Patient was hospitalized.

Hypoglycaemic Seizure, Blood Glucose Decreased
Adverse event was reported on Jan 09, 2014 by a Female taking Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l (Dosage: N/A) . Location: US , 87 years of age, weighting 149.9 lb, Directly after, patient experienced the unwanted or unexpected Levemir side effects: hypoglycaemic seizure, blood glucose decreased.

Device Breakage, Hyperglycaemic Seizure
on Jan 09, 2014 Male from US , 65 years of age, was diagnosed with and was treated with Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. Patient felt the following Levemir side effects: device breakage, hyperglycaemic seizure. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A. Patient was hospitalized.

Diabetic Ketoacidosis
on Jan 09, 2014 Male from US , 75 years of age, weighting 207.0 lb, was diagnosed with and was treated with Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. After Levemir was administered, patient encountered several Levemir side effects: diabetic ketoacidosis. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A. Patient was hospitalized.

Anaphylactic Reaction
Patient was taking Levemir (insulin Detemir) Solution For Injection, .0024mol/l. Directly after, patient experienced the unwanted or unexpected Levemir side effects: anaphylactic reaction on Jan 09, 2014 from US Additional patient health information: Female , 44 years of age, weighting 175.0 lb, was diagnosed with and. Levemir (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A.
Associated medications used:
  • Synthroid (levothyroxine Sodium)


Blood Glucose Increased
Adverse event was reported on Jan 09, 2014 by a Male taking Levemir (insulin Detemir) Solution For Injection, .0024mol/l (Dosage: N/A) was diagnosed with and. Location: US , 76 years of age, Patient felt the following Levemir side effects: blood glucose increased.

Blood Glucose Increased
on Jan 09, 2014 Male from US , 21 years of age, was diagnosed with and was treated with Levemir. After Levemir was administered, patient encountered several Levemir side effects: blood glucose increased. Levemir dosage: 20 U, Qd, Subcutaneous?.

Blood Glucose Increased, Hypertension, Pneumonia
on Jan 09, 2014 Female from US , 57 years of age, was diagnosed with and was treated with Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l. Directly after, patient experienced the unwanted or unexpected Levemir side effects: blood glucose increased, hypertension, pneumonia. Levemir Flexpen (insulin Detemir) Solution For Injection, .0024mol/l dosage: N/A.
Associated medications used:
  • Glumetza (metformin Hydrochloride)
  • Lisinopril/hctz (hydrochlorothiazide, Lisinopril)
  • Januvia (sitagliptin Phosphate)


1 of 127 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Levemir Side Effects

    Did You Have a Levemir Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Levemir for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative LEVEMIR Names:INSULIN D

    Active Ingredient: INSULIN D

    Levemir Dosage, Warnings, Usage.

    Side Effects reported to FDA: 3166

    Levemir safety alerts: 2009

    Reported deaths: 171

    Reported hospitalizations: 790

    Levemir Insulin (Novo Nordisk)

    Audience: Patients, pharmacists, diabetes healthcare professionals

    [UPDATED 08/26/2009]  FDA is reminding the public that stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. still may be on the market. Evidence gathered to date suggests that the stolen insulin was not stored and handled properly and may be dangerous for people to use. FDA has received multiple reports of patients who suffered an adverse event due to poor control of glucose levels after using a vial from one of the stolen lots.

    [Posted 06/13/2009] FDA notified patients and healthcare professionals that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. are being sold in the U.S. market, may not have been stored and handled properly, and may be dangerous for patients to use. The agency is advising patients who use Levemir insulin to:

    • Check your personal supply of insulin to determine if you have Levemir insulin from one of the following lots: XZF0036, XZF0037, and XZF0038. 
    • Do not use your Levemir insulin if it is from one of these lots.
    • Always visually inspect your insulin before using it. Levemir is a clear and colorless solution.
    • Contact the Novo Nordisk Customer Care Center at 1-800-727-6500 for what to do with vials from these lots or if you have any other questions.

    [08/26/2009 - News Release- FDA]
    [08/04/2009 - Patient Safety News video - FDA YouTube Channel]
    [06/13/2009 - News Release - FDA]

    Latest Levemir clinical trials